Post Profile






FDA approves Novo Nordisk diabetes drug Ozempic

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli Lilly & Co's Trulicity.
read more

share
See more about: Eli Lilly

Related Posts


Business Briefing: F.D.A. Approves Trulicity, a Drug for Type 2 Diabetes

Health : NYTimes: Health

The Food and Drug Administration has approved a new injectable diabetes drug from Eli Lilly for adults with the most common form of the disease.

Eli Lilly Gets European Approval to Sell Trulicity, a Type 2 Diabetes Drug

Health : NYTimes: Health

The move by the European Commission puts pressure on the company’s Danish rival, Novo Nordisk, the market leader in its category.

Comments


Copyright © 2016 Regator, LLC